8-K 1 g69718e8-k.txt IVAX CORPORATION - 8-K MAY 24, 2001 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): MAY 18, 2001 Commission File Number 1-09623 IVAX CORPORATION FLORIDA 16-1003559 ------------------------------- ------------------- (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) 4400 BISCAYNE BOULEVARD, MIAMI, FLORIDA 33137 ------------------------------------------- ---------- (Address of principal executive offices) (Zip Code) (305) 575-6000 ---------------------------------------------------- (Registrant's telephone number, including area code) 2 ITEM 5 - OTHER EVENTS AND REGULATION FD DISCLOSURE On May 18, 2001, IVAX Corporation ("IVAX") entered into an agreement (the "Agreement") with Comercial e Inversiones Portfolio Limitada and Inversiones Portfolio S.A. (collectively, "Portfolio"), the largest shareholders of Laboratorio Chile S.A., to make a cash tender offer for all of the common stock of Laboratorio Chile, a pharmaceutical company having common stock traded on the Santiago exchange and American Depository Receipts ("ADRs") traded on the New York Stock Exchange. Portfolio has agreed to tender its shares to IVAX in the tender offer, which will soon be launched simultaneously in Chile and the United States at a price of US$1.25 per share, or US$25.00 per ADR. The cash to be used to purchase the shares of Laboratorio Chile which are tendered will come from cash on hand. Laboratorio Chile manufactures, markets and distributes pharmaceutical products in Chile, Argentina and Peru. IVAX issued a press release regarding the tender offer on May 21, 2001 (the "Press Release"). This Current Report on Form 8-K is qualified in its entirety by, and should be read in conjunction with, the Agreement, the Press Release and other documents filed as exhibits to this report and incorporated herein by reference. 2 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. IVAX CORPORATION Date: May 24, 2001 By: /s/ THOMAS E. BEIER ----------------------------------- Thomas E. Beier Senior Vice President-Finance Chief Financial Officer 3 4 EXHIBIT INDEX EXHIBIT ------- 10.29 Agreement to Tender dated as of May 18, 2001, among IVAX Corporation, Comercial e Inversiones Portfolio Limitada and Inversiones Portfolio S.A. 99.1 Press Release dated May 21, 2001, issued by IVAX Corporation. 4